Use of virus or viral component as vaccine

Industry

CPC
C12N2760/10034

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2760/00ssRNA Viruses negative-sense

Current Industry

C12N2760/10034Use of virus or viral component as vaccine

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Lassa virus vaccine
- Patent number 12,161,711
- Issue date Dec 10, 2024
- CureVac SE
- Edith Jasny
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric molecules and uses thereof
- Patent number 12,116,386
- Issue date Oct 15, 2024
- The University of Queensland
- Keith Joseph Chappell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lassa vaccine
- Patent number 11,976,305
- Issue date May 7, 2024
- Institut Pasteur
- Mathieu Mateo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication-deficient modified vaccinia Ankara (MVA) expressing Mar...
- Patent number 11,896,657
- Issue date Feb 13, 2024
- Geovax, Inc.
- Harriet Robinson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HBV vaccines and methods treating HBV
- Patent number 11,730,808
- Issue date Aug 22, 2023
- Gilead Sciences, Inc.
- Scott J. Balsitis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication-deficient modified vaccinia Ankara (MVA) expressing Ebo...
- Patent number 11,701,418
- Issue date Jul 18, 2023
- Geovax, Inc.
- Harriet Latham Robinson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activation of resident memory T cells for cancer immunotherapy
- Patent number 11,642,401
- Issue date May 9, 2023
- Regents of The University of Minnesota
- David B. Masopust
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunogenic composition comprising a recombinant attenuated mopeia...
- Patent number 11,638,751
- Issue date May 2, 2023
- Institut Pasteur
- Sylvain Baize
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HBV vaccines and methods treating HBV
- Patent number 11,497,808
- Issue date Nov 15, 2022
- Gilead Sciences, Inc.
- Scott J. Balsitis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lassa virus vaccine
- Patent number 11,464,847
- Issue date Oct 11, 2022
- CureVac AG
- Edith Jasny
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication-defective arenavirus vectors
- Patent number 11,401,528
- Issue date Aug 2, 2022
- Universitat Zurich
- Daniel D. Pinschewer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric molecules and uses thereof
- Patent number 11,254,712
- Issue date Feb 22, 2022
- The University of Queensland
- Keith Joseph Chappell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vaccines against hepatitis B virus
- Patent number 11,214,598
- Issue date Jan 4, 2022
- Hookipa Biotech GmbH
- Thomas Monath
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vaccines with interleukin-33 as an adjuvant
- Patent number 10,933,130
- Issue date Mar 2, 2021
- The Trustees of the University of Pennsylvania
- David Weiner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant attenuated Mopeia virus comprising a modified nucleopro...
- Patent number 10,849,969
- Issue date Dec 1, 2020
- Institut Pasteur
- Sylvain Baize
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activation of resident memory T cells for cancer immunotherapy
- Patent number 10,722,537
- Issue date Jul 28, 2020
- Regents of The University of Minnesota
- David B. Masopust
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tri-segmented arenaviruses as vaccine vectors
- Patent number 10,722,564
- Issue date Jul 28, 2020
- Universite de Geneve
- Daniel David Pinschewer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Replication-defective arenavirus vectors
- Patent number 10,655,145
- Issue date May 19, 2020
- Universitat Zurich
- Daniel D. Pinschewer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arenavirus vaccine
- Patent number 10,342,861
- Issue date Jul 9, 2019
- University of Rochester
- Luis Martinez-Sobrido
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccines with interleukin-33 as an adjuvant
- Patent number 10,130,705
- Issue date Nov 20, 2018
- The Trustees of the University of Pennsylvania
- David Weiner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions related to reorganization of arenavirus ge...
- Patent number 9,943,585
- Issue date Apr 17, 2018
- University of Rochester
- Juan Carlos de la Torre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Replication-defective arenavirus vectors
- Patent number 9,944,952
- Issue date Apr 17, 2018
- Universitat Zurich
- Daniel D. Pinschewer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthetic viruses and uses thereof
- Patent number 9,765,304
- Issue date Sep 19, 2017
- L'Universite Pierre et Marie Curie
- David Klatzmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Microparticulated vaccines for the oral or nasal vaccination and bo...
- Patent number 9,623,094
- Issue date Apr 18, 2017
- Advanced BioNutrition Corporation
- Moti Harel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant bacterium and uses thereof
- Patent number 9,539,313
- Issue date Jan 10, 2017
- National Research Council of Canada
- Subash Sad
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-protective arenavirus vaccines and their method of use
- Patent number 9,446,114
- Issue date Sep 20, 2016
- Inovio Pharmaceuticals, Inc.
- Kate Broderick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-epitopic vaccine
- Patent number 9,187,534
- Issue date Nov 17, 2015
- UNIVERSITE DE GENEVE
- Madiha Sabiha Derouazi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of mTOR inhibitors to enhance T cell immune responses
- Patent number 8,840,899
- Issue date Sep 23, 2014
- Emory University
- Rafi Ahmed
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pre-or post-exposure treatment for filovirus or arenavirus infection
- Patent number 8,796,013
- Issue date Aug 5, 2014
- Trustees of Boston University
- Thomas W. Geisbert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthetic viruses and uses thereof
- Patent number 8,673,612
- Issue date Mar 18, 2014
- L'Universite Pierre et Marie Curie
- David Klatzmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE
- Publication number 20240228549
- Publication date Jul 11, 2024
- The USA, as represented by the Secretary, Department of Health and Human Serv...
- Peter Kwong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ARENAVIRUSES USED IN TREATMENTS OF PROSTATE CANCER
- Publication number 20240174724
- Publication date May 30, 2024
- Hookipa Biotech GmbH
- Igor Matushansky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REPLICATION-DEFICIENT MODIFIED VACCINIA ANKARA (MVA) EXPRESSING MAR...
- Publication number 20240156940
- Publication date May 16, 2024
- GeoVax, Inc.
- Harriet Robinson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRI-SEGMENTED ARENAVIRUSES AS VACCINE VECTORS
- Publication number 20240082376
- Publication date Mar 14, 2024
- UNIVERSITE DE GENEVE
- Daniel David Pinschewer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTIVATION OF RESIDENT MEMORY T CELLS FOR CANCER IMMUNOTHERAPY
- Publication number 20240041996
- Publication date Feb 8, 2024
- Regents of the University of Minnesota
- David B. Masopust
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED ARENAVIRUS GLYCOPROTEIN COMPOSITIONS AND METHODS OF USE...
- Publication number 20230310568
- Publication date Oct 5, 2023
- LA JOLLA INSTITUTE FOR IMMUNOLOGY
- Erica Ollmann Saphire
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARENAVIRUSES AS VECTORS
- Publication number 20220380805
- Publication date Dec 1, 2022
- UNIVERSITAT BASEL
- Daniel PINSCHEWER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRI-SEGMENTED PICHINDE VIRUSES AS VACCINE VECTORS
- Publication number 20220289797
- Publication date Sep 15, 2022
- Hookipa Biotech GmbH
- Weldi Bonilla
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REPLICATION-DEFICIENT MODIFIED VACCINIA ANKARA (MVA) EXPRESSING MAR...
- Publication number 20220152190
- Publication date May 19, 2022
- GEOVAX, INC.
- Harriett Robinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC MOLECULES AND USES THEREOF
- Publication number 20220127309
- Publication date Apr 28, 2022
- THE University of Queensland
- Keith Joseph CHAPPELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINES AND METHODS
- Publication number 20220040284
- Publication date Feb 10, 2022
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY CAMBRIDGE
- Jonathan Luke HEENEY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL LASSA VIRUS RNA MOLECULES AND COMPOSITIONS FOR VACCINATION
- Publication number 20210260178
- Publication date Aug 26, 2021
- CureVac AG
- Edith JASNY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEOTIDE VACCINE
- Publication number 20210230633
- Publication date Jul 29, 2021
- Copenhagen University
- Peter Johannes Holst
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
TRI-SEGMENTED ARENAVIRUSES AS VACCINE VECTORS
- Publication number 20210145950
- Publication date May 20, 2021
- UNIVERSITE DE GENEVE
- Daniel David Pinschewer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HBV VACCINES AND METHODS TREATING HBV
- Publication number 20210093712
- Publication date Apr 1, 2021
- GILEAD SCIENCES, INC.
- Scott J. Balsitis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATION OF RESIDENT MEMORY T CELLS FOR CANCER IMMUNOTHERAPY
- Publication number 20210000935
- Publication date Jan 7, 2021
- Regents of the University of Minnesota
- David B. Masopust
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LASSA VACCINE
- Publication number 20200308555
- Publication date Oct 1, 2020
- INSTITUT PASTEUR
- Mathieu MATEO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
- Publication number 20200223926
- Publication date Jul 16, 2020
- Emory University
- Rafi Ahmed
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ARENAVIRUS PARTICLES TO TREAT SOLID TUMORS
- Publication number 20200113995
- Publication date Apr 16, 2020
- Hookipa Biotech GmbH
- Klaus Orlinger
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC MOLECULES AND USES THEREOF
- Publication number 20200040042
- Publication date Feb 6, 2020
- THE University of Queensland
- Keith Joseph CHAPPELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LASSA VIRUS VACCINE
- Publication number 20190351044
- Publication date Nov 21, 2019
- CureVac AG
- Edith JASNY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Microparticulated Vaccines for the Oral or Nasal Vaccination and Bo...
- Publication number 20190192654
- Publication date Jun 27, 2019
- Intervet Inc.
- Mordechai Harel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRI-SEGMENTED PICHINDE VIRUSES AS VACCINE VECTORS
- Publication number 20190135875
- Publication date May 9, 2019
- Hookipa Biotech GmbH
- Weldi Bonilla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Generating an Immune Response to a Hem...
- Publication number 20190117758
- Publication date Apr 25, 2019
- GeoVax, Inc.
- Harriet Latham Robinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REPLICATION-DEFECTIVE ARENAVIRUS VECTORS
- Publication number 20190062784
- Publication date Feb 28, 2019
- Universitat Zurich
- Daniel D. Pinschewer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
- Publication number 20190031758
- Publication date Jan 31, 2019
- Emory University
- Rafi Ahmed
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINES WITH INTERLEUKIN-33 AS AN ADJUVANT
- Publication number 20180360958
- Publication date Dec 20, 2018
- The Trustees of the University of Pennsylvania
- David Weiner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
- Publication number 20180155430
- Publication date Jun 7, 2018
- Emory University
- Rafi Ahmed
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
In Vivo Activation of Antigen Presenting Cells for Enhancement of I...
- Publication number 20180015160
- Publication date Jan 18, 2018
- KUROS BIOSCIENCES AG
- Martin F. BACHMANN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRI-SEGMENTED ARENAVIRUSES AS VACCINE VECTORS
- Publication number 20170319673
- Publication date Nov 9, 2017
- UNIVERSITE DE GENEVE
- Daniel David Pinschewer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Use of virus or viral component as vaccine

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Lassa virus vaccine

Chimeric molecules and uses thereof

Lassa vaccine

Replication-deficient modified vaccinia Ankara (MVA) expressing Mar...

HBV vaccines and methods treating HBV

Replication-deficient modified vaccinia Ankara (MVA) expressing Ebo...

Activation of resident memory T cells for cancer immunotherapy

Immunogenic composition comprising a recombinant attenuated mopeia...

HBV vaccines and methods treating HBV

Lassa virus vaccine

Replication-defective arenavirus vectors

Chimeric molecules and uses thereof

Vaccines against hepatitis B virus

Vaccines with interleukin-33 as an adjuvant

Recombinant attenuated Mopeia virus comprising a modified nucleopro...

Activation of resident memory T cells for cancer immunotherapy

Tri-segmented arenaviruses as vaccine vectors

Replication-defective arenavirus vectors

Arenavirus vaccine

Vaccines with interleukin-33 as an adjuvant

Methods and compositions related to reorganization of arenavirus ge...

Replication-defective arenavirus vectors

Synthetic viruses and uses thereof

Microparticulated vaccines for the oral or nasal vaccination and bo...

Recombinant bacterium and uses thereof

Cross-protective arenavirus vaccines and their method of use

Multi-epitopic vaccine

Use of mTOR inhibitors to enhance T cell immune responses

Pre-or post-exposure treatment for filovirus or arenavirus infection

Synthetic viruses and uses thereof

Patents Applicationslast 30 patents

PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE

ARENAVIRUSES USED IN TREATMENTS OF PROSTATE CANCER

REPLICATION-DEFICIENT MODIFIED VACCINIA ANKARA (MVA) EXPRESSING MAR...

TRI-SEGMENTED ARENAVIRUSES AS VACCINE VECTORS

ACTIVATION OF RESIDENT MEMORY T CELLS FOR CANCER IMMUNOTHERAPY

ENGINEERED ARENAVIRUS GLYCOPROTEIN COMPOSITIONS AND METHODS OF USE...

ARENAVIRUSES AS VECTORS

TRI-SEGMENTED PICHINDE VIRUSES AS VACCINE VECTORS

REPLICATION-DEFICIENT MODIFIED VACCINIA ANKARA (MVA) EXPRESSING MAR...

CHIMERIC MOLECULES AND USES THEREOF

VACCINES AND METHODS

NOVEL LASSA VIRUS RNA MOLECULES AND COMPOSITIONS FOR VACCINATION

NUCLEOTIDE VACCINE

TRI-SEGMENTED ARENAVIRUSES AS VACCINE VECTORS

HBV VACCINES AND METHODS TREATING HBV

ACTIVATION OF RESIDENT MEMORY T CELLS FOR CANCER IMMUNOTHERAPY

LASSA VACCINE

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

ARENAVIRUS PARTICLES TO TREAT SOLID TUMORS

CHIMERIC MOLECULES AND USES THEREOF

LASSA VIRUS VACCINE

Microparticulated Vaccines for the Oral or Nasal Vaccination and Bo...

TRI-SEGMENTED PICHINDE VIRUSES AS VACCINE VECTORS

Compositions and Methods for Generating an Immune Response to a Hem...

REPLICATION-DEFECTIVE ARENAVIRUS VECTORS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

VACCINES WITH INTERLEUKIN-33 AS AN ADJUVANT

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

In Vivo Activation of Antigen Presenting Cells for Enhancement of I...

TRI-SEGMENTED ARENAVIRUSES AS VACCINE VECTORS